CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-06 | David Glenn Chief Financial Officer | Grant or award | +3,482 | 54,959 | ||
| 2026-08-06 | Miller Larry Lee Chief Operating Officer | Grant or award | +3,726 | 38,275 | ||
| 2026-08-06 | Rodriguez Patrick VP Finance and Treasurer | Grant or award | +1,503 | 1,503 | ||
| 2026-08-06 | David Glenn Chief Financial Officer | Grant or award | +3,334 | 54,811 | ||
| 2026-08-06 | Miller Larry Lee Chief Operating Officer | Grant or award | +3,522 | 38,071 | ||
| 2026-08-06 | BENDHEIM Jonathan Director | Grant or award | +2,716 | 5,984 | ||
| 2026-08-06 | Weinstein Judith See Remarks | Grant or award | +2,478 | 5,453 | ||
| 2026-08-06 | BENDHEIM JACK Executive Chairman | Grant or award | +12,103 | 26,640 | ||
| 2026-08-06 | Escudero Lisa Ann See Remarks | Grant or award | +1,547 | 3,434 | ||
| 2026-08-06 | Bendheim Daniel M President and CEO | Grant or award | +11,699 | 15,177 | ||
| 2026-08-04 | BENDHEIM JACK Executive Chairman | Other disposition | −2,303 | $36.60 | $84K | 14,537 |
| 2026-08-04 | Escudero Lisa Ann See Remarks | Other disposition | −265 | $36.60 | $10K | 1,887 |
| 2026-08-04 | Miller Larry Lee Chief Operating Officer | Other disposition | −635 | $36.60 | $23K | 34,549 |
| 2026-08-04 | Weinstein Judith See Remarks | Other disposition | −472 | $36.60 | $17K | 2,975 |
| 2026-08-04 | David Glenn Chief Financial Officer | Other disposition | −840 | $36.60 | $31K | 51,477 |
| 2026-08-04 | Bendheim Daniel M President and CEO | Other disposition | −486 | $36.60 | $18K | 3,478 |
| 2026-07-01 | Bendheim Daniel M President and CEO | Grant or award · Performance Stock Units | +300,000 | 300,000 | ||
| 2026-05-29 | CORCORAN E THOMAS Director | Purchase | +10,000 | $31.77 | $318K | 41,459 |
| 2026-05-07 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −1,350 | $47.59 | $64K | 59,330 |
| 2026-05-07 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −1,149 | $48.31 | $56K | 58,181 |
Page 1 of 18 · 343 trades